MobbleOpen in Mobble ⇢
Business · Stock markets · published 2026-10-13 · via MarketBeat

KeyCorp Repeats Overweight Rating and $900 Target for Meta Platforms

Image via MarketBeat
Image via MarketBeat

KeyCorp restated its overweight rating on Meta Platforms and maintained a $900 price target, implying about 21.14% upside. The consensus rating was Moderate Buy with an average target of $796.12. Meta’s latest quarter showed 28% year-over-year revenue growth to $60.80 billion, but earnings of $6.18 per share missed estimates, and insiders sold more than $101 million in stock over three months.

Expanded Detail

KeyCorp kept its overweight call on Meta and a $900 target, which would represent roughly 21.14% upside from the prior close. Other firms are mixed: Wells Fargo lifted its target to $1,000, Piper Sandler to $875, Monness Crespi & Hardt to $830, and Bernstein to $800, while BMO lowered its target to $580.

Meta's most recent quarter produced $60.80 billion in revenue, 28% higher than a year earlier, but EPS of $6.18 fell short of the $7.19 consensus. The shares opened at $742.96, with a $1.89 trillion market value, a 27.98 P/E, and a 52-week range of $520.26 to $779.82. Insiders sold over $101 million in three months.

Context

A reiterated bullish call and high target may influence retail and institutional investors watching Meta, potentially shaping portfolio decisions and market sentiment around large technology stocks. If Meta's revenue growth continues while earnings disappoint, advertisers, employees, and shareholders could face uneven effects, as ad demand, hiring, and share prices may shift. Analyst optimism may also amplify attention on insider sales, though such signals are not necessarily predictive.

Expanded detail and Context are AI-generated analysis; the linked article remains the authoritative source.
Read the full article at MarketBeat →
Related stories
KeyCorp Cuts Netflix Price Target to $85 but Stays Overweight · Stock markets
Ring Mountain Capital Trims Meta Platforms Stake · Stock markets
Truist Lowers Nurix Therapeutics Target to $33, Keeps Buy Rating · Stock markets
McGlone Suttner Opens Position in C.H. Robinson Worldwide · Stock markets
This summary is Al-enhanced to contain extended analysis and broader social context. The original is {NAME); the linked article is the authoritative source. Original headline: “KeyCorp Reaffirms Overweight Rating for Meta Platforms (NASDAQ:META).” Browse more stories.